⌘K

Login Start Free

Home/Filings/4/0001213900-15-001820

4//SEC Filing

Actinium Pharmaceuticals, Inc. 4

Accession 0001213900-15-001820

$ATNMCIK 0001388320operating

View on SEC.gov Company Profile

Filed

Mar 15, 8:00 PM ET

Accepted

Mar 16, 5:26 PM ET

Size

9.2 KB

Accession

0001213900-15-001820

Insider Transaction Report

Form 4

Period: 2014-02-21

Actinium Pharmaceuticals, Inc.ATNM

COO and CMO

Transactions

Award
Common Stock
2014-02-21$5.55/sh+3,500$19,425→ 3,500 total
Award
Options to purchase common stock
2014-02-21$5.55/sh+31,500$174,825→ 31,500 total
Exercise: $5.55Exp: 2024-02-21→ Common stock (31,500 underlying)
Award
Options to purchase common stock
2015-02-18$3.58/sh+35,000$125,300→ 35,000 total
Exercise: $3.58Exp: 2025-02-18→ Common stock (35,000 underlying)

Footnotes (1)

[F1]Pursuant to the terms of the company's Amended and Restated 2013 Stock Plan, 2% of the options shall vest each month from the date of grant.

Documents

1 file

4
f4021815cicic_actinium.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

Actinium Pharmaceuticals, Inc.

CIK 0001388320

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0001388320

Filing Metadata

Form type: 4
Filed: Mar 15, 8:00 PM ET
Accepted: Mar 16, 5:26 PM ET
Size: 9.2 KB

View on SEC.gov